Stay updated on EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial
Sign up to get notified when there's something new on the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page.

Latest updates to the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page
- Check5 days agoChange DetectedThe page now shows Revision: v3.6.5, replacing v3.6.4, indicating a minor version update to the page. No study details appear to be changed by this revision.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous revision label v3.6.3. This indicates an update to the page's revision/version metadata.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe page revision tag was updated from v3.6.2 to v3.6.3, signaling a small version update. This change does not modify any study information or visible content.SummaryDifference0.0%

- Check48 days agoChange DetectedThe study page revision was updated from v3.6.0 to v3.6.2, indicating a newer version of the page.SummaryDifference0.0%

- Check62 days agoChange DetectedNew help/navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment section was updated; the recruitment note now shows No longer looking for participants, and the page revision updated to v3.6.0.SummaryDifference0.4%

- Check69 days agoChange DetectedEndo Pharmaceuticals was replaced with Endo USA Inc., a Keenova Therapeutics Company as the sponsor. The document revision was updated from v3.5.4 to v3.5.5.SummaryDifference0.3%

Stay in the know with updates to EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EN3835 for Edematous Fibrosclerotic Panniculopathy Clinical Trial page.